Table 2 Multivariable logistic regression model results for prediction of prostate cancer detection based on sarcosine and standard risk factors
From: A case control study of sarcosine as an early prostate cancer detection biomarker
Odds ratio (95 % confidence interval) | P-value | |
|---|---|---|
Age | 1.0 (0.9–1.1) | 0.11 |
Race | ||
African American | 1.3 (0.6–3.0) | 0.47 |
Other | 1.2 (0.7–2.3) | 0.49 |
At least one previous prostate biopsy | 0.7 (0.3–1.3) | 0.26 |
Abnormal Digital Rectal Exam | 30.5 (11.8–92.2) | <0.001 |
Family history of prostate cancer | 3.5 (1.8–6.8) | <0.001 |
Prostate-specific antigen (ng/mL)a | 4.4 (3.3–5.9) | <0.001 |
Sarcosine uM in 20uL seruma | 1.1 (0.7–1.8) | 0.64 |